| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nidovirales | 11 | 2019 | 109 | 3.08 | Why? |
| Arterivirus | 13 | 2019 | 77 | 2.88 | Why? |
| Virus Replication | 45 | 2020 | 14331 | 2.51 | Why? |
| Transcription, Genetic | 14 | 2018 | 1326 | 1.87 | Why? |
| Endoplasmic Reticulum | 7 | 2020 | 430 | 1.63 | Why? |
| Viral Nonstructural Proteins | 30 | 2021 | 4810 | 1.46 | Why? |
| SARS Virus | 32 | 2020 | 13021 | 1.29 | Why? |
| Arterivirus Infections | 5 | 2016 | 23 | 1.13 | Why? |
| Gene Expression Regulation, Viral | 10 | 2016 | 925 | 1.06 | Why? |
| RNA, Viral | 42 | 2020 | 32276 | 1.00 | Why? |
| DNA-Directed RNA Polymerases | 6 | 2017 | 239 | 0.96 | Why? |
| Viral Proteins | 23 | 2020 | 7370 | 0.81 | Why? |
| Molecular Sequence Data | 34 | 2015 | 3198 | 0.81 | Why? |
| Intracellular Membranes | 5 | 2020 | 103 | 0.78 | Why? |
| Exoribonucleases | 4 | 2020 | 455 | 0.76 | Why? |
| Cyclophilins | 2 | 2019 | 76 | 0.75 | Why? |
| Cyclosporine | 4 | 2019 | 449 | 0.70 | Why? |
| Cell Line | 26 | 2021 | 12040 | 0.70 | Why? |
| Cyclophilin A | 1 | 2017 | 90 | 0.67 | Why? |
| RNA, Messenger | 16 | 2018 | 5131 | 0.63 | Why? |
| Murine hepatitis virus | 9 | 2020 | 1720 | 0.61 | Why? |
| Virus Cultivation | 2 | 2018 | 579 | 0.57 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 8 | 2020 | 8843 | 0.57 | Why? |
| Torovirus | 4 | 2018 | 59 | 0.56 | Why? |
| Genome, Viral | 19 | 2020 | 13157 | 0.54 | Why? |
| RNA | 5 | 2014 | 1278 | 0.51 | Why? |
| Animals | 59 | 2021 | 78931 | 0.51 | Why? |
| Endoribonucleases | 2 | 2009 | 407 | 0.50 | Why? |
| Nucleic Acid Conformation | 7 | 2020 | 621 | 0.48 | Why? |
| Coronavirus 229E, Human | 4 | 2014 | 1241 | 0.47 | Why? |
| Cytopathogenic Effect, Viral | 4 | 2020 | 635 | 0.46 | Why? |
| Coronavirus | 18 | 2020 | 18339 | 0.43 | Why? |
| RNA Helicases | 7 | 2016 | 413 | 0.41 | Why? |
| Coronaviridae | 7 | 2018 | 923 | 0.41 | Why? |
| Immune Sera | 2 | 2020 | 884 | 0.40 | Why? |
| Vero Cells | 18 | 2021 | 14117 | 0.40 | Why? |
| Host-Pathogen Interactions | 9 | 2020 | 11041 | 0.39 | Why? |
| Methyltransferases | 5 | 2016 | 720 | 0.39 | Why? |
| Conserved Sequence | 5 | 2020 | 751 | 0.38 | Why? |
| Cytoplasmic Vesicles | 2 | 2020 | 74 | 0.38 | Why? |
| Base Sequence | 18 | 2021 | 3581 | 0.37 | Why? |
| Suramin | 2 | 2020 | 76 | 0.37 | Why? |
| Protein Biosynthesis | 6 | 2018 | 653 | 0.37 | Why? |
| Electron Microscope Tomography | 5 | 2020 | 167 | 0.36 | Why? |
| Rabbits | 4 | 2020 | 1171 | 0.36 | Why? |
| Amino Acid Sequence | 25 | 2016 | 6049 | 0.36 | Why? |
| RNA Viruses | 8 | 2019 | 824 | 0.34 | Why? |
| Porcine respiratory and reproductive syndrome virus | 2 | 2018 | 91 | 0.34 | Why? |
| Papain | 4 | 2014 | 257 | 0.34 | Why? |
| Mutagenesis, Site-Directed | 6 | 2011 | 449 | 0.33 | Why? |
| Green Fluorescent Proteins | 2 | 2011 | 450 | 0.33 | Why? |
| Replication Origin | 1 | 2006 | 16 | 0.33 | Why? |
| Transport Vesicles | 1 | 2006 | 27 | 0.32 | Why? |
| Organelles | 2 | 2017 | 45 | 0.32 | Why? |
| Genes, Reporter | 2 | 2011 | 472 | 0.32 | Why? |
| Microscopy, Fluorescence | 3 | 2020 | 335 | 0.31 | Why? |
| Small Molecule Libraries | 1 | 2014 | 1060 | 0.30 | Why? |
| Zinc Fingers | 3 | 2020 | 109 | 0.30 | Why? |
| Methylation | 4 | 2020 | 332 | 0.29 | Why? |
| Open Reading Frames | 12 | 2015 | 1898 | 0.29 | Why? |
| Enterovirus | 2 | 2020 | 402 | 0.28 | Why? |
| Virion | 3 | 2017 | 1444 | 0.28 | Why? |
| Sequence Homology, Amino Acid | 8 | 2016 | 945 | 0.28 | Why? |
| Viral Plaque Assay | 3 | 2020 | 381 | 0.28 | Why? |
| Antisense Elements (Genetics) | 1 | 2003 | 10 | 0.26 | Why? |
| Coronavirus, Feline | 4 | 2010 | 581 | 0.25 | Why? |
| Cricetinae | 4 | 2017 | 3344 | 0.25 | Why? |
| Virology | 1 | 2007 | 489 | 0.24 | Why? |
| Peptide Hydrolases | 2 | 2007 | 1269 | 0.24 | Why? |
| Microscopy, Electron | 2 | 2020 | 830 | 0.24 | Why? |
| DNA Helicases | 3 | 2012 | 203 | 0.22 | Why? |
| RNA, Double-Stranded | 3 | 2018 | 226 | 0.22 | Why? |
| Cell Membrane | 3 | 2016 | 743 | 0.21 | Why? |
| Antiviral Agents | 13 | 2020 | 41703 | 0.21 | Why? |
| Ubiquitin | 2 | 2014 | 243 | 0.21 | Why? |
| Lactams | 1 | 2020 | 50 | 0.21 | Why? |
| RNA, Antisense | 1 | 1999 | 39 | 0.21 | Why? |
| Fluorouracil | 1 | 2020 | 169 | 0.20 | Why? |
| Base Pairing | 1 | 1999 | 73 | 0.20 | Why? |
| Gene Knockout Techniques | 1 | 2020 | 347 | 0.20 | Why? |
| RNA Caps | 3 | 2016 | 204 | 0.20 | Why? |
| Adaptation, Biological | 1 | 2020 | 179 | 0.19 | Why? |
| Peptidylprolyl Isomerase | 1 | 2018 | 10 | 0.19 | Why? |
| Archaeal Proteins | 2 | 2015 | 45 | 0.19 | Why? |
| Acid Anhydride Hydrolases | 2 | 2016 | 16 | 0.19 | Why? |
| Genes, Viral | 6 | 2012 | 1428 | 0.18 | Why? |
| Protein Multimerization | 2 | 2017 | 1336 | 0.18 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3633 | 0.18 | Why? |
| Porcine Reproductive and Respiratory Syndrome | 1 | 2018 | 47 | 0.18 | Why? |
| Peptidomimetics | 1 | 2020 | 202 | 0.18 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 49 | 0.17 | Why? |
| Minor Histocompatibility Antigens | 1 | 2017 | 56 | 0.17 | Why? |
| Virus Release | 2 | 2017 | 253 | 0.17 | Why? |
| Sequence Alignment | 8 | 2015 | 2109 | 0.17 | Why? |
| Ribose | 1 | 2016 | 42 | 0.16 | Why? |
| Catalytic Domain | 3 | 2020 | 1757 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 8 | 2018 | 12361 | 0.16 | Why? |
| Cycloheximide | 2 | 2011 | 12 | 0.16 | Why? |
| Protein Synthesis Inhibitors | 2 | 2011 | 32 | 0.16 | Why? |
| Protein Processing, Post-Translational | 3 | 2015 | 634 | 0.15 | Why? |
| Fluorescent Antibody Technique | 2 | 2010 | 835 | 0.15 | Why? |
| Protein Structure, Tertiary | 6 | 2016 | 1565 | 0.15 | Why? |
| Crystallography, X-Ray | 9 | 2020 | 2689 | 0.15 | Why? |
| Polyproteins | 2 | 2015 | 814 | 0.15 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.15 | Why? |
| RNA Processing, Post-Transcriptional | 2 | 2008 | 110 | 0.15 | Why? |
| Substrate Specificity | 4 | 2012 | 639 | 0.15 | Why? |
| Mice | 8 | 2020 | 21357 | 0.15 | Why? |
| Amino Acid Motifs | 3 | 2014 | 620 | 0.14 | Why? |
| Biological Evolution | 6 | 2006 | 641 | 0.14 | Why? |
| Adenosine | 1 | 2019 | 509 | 0.14 | Why? |
| Loperamide | 1 | 2014 | 13 | 0.14 | Why? |
| Nucleotidyltransferases | 1 | 2015 | 77 | 0.14 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.14 | Why? |
| Benzamides | 1 | 2018 | 421 | 0.14 | Why? |
| Evolution, Molecular | 2 | 2006 | 3691 | 0.14 | Why? |
| Protein Kinases | 1 | 2015 | 93 | 0.14 | Why? |
| Nucleic Acids | 2 | 2012 | 435 | 0.14 | Why? |
| Acyclovir | 1 | 2015 | 154 | 0.14 | Why? |
| Recombination, Genetic | 5 | 2012 | 1265 | 0.14 | Why? |
| Phosphoric Monoester Hydrolases | 2 | 2011 | 37 | 0.14 | Why? |
| Nucleotides | 3 | 2015 | 212 | 0.14 | Why? |
| Metagenomics | 1 | 2020 | 823 | 0.13 | Why? |
| Horses | 4 | 2018 | 474 | 0.13 | Why? |
| Mutation | 9 | 2020 | 12376 | 0.13 | Why? |
| Interferon-alpha | 2 | 2013 | 1442 | 0.13 | Why? |
| Multiprotein Complexes | 1 | 2014 | 182 | 0.13 | Why? |
| Biocatalysis | 2 | 2014 | 100 | 0.13 | Why? |
| Manganese | 2 | 2015 | 111 | 0.13 | Why? |
| Chlorpromazine | 1 | 2014 | 130 | 0.13 | Why? |
| Protein Subunits | 2 | 2008 | 755 | 0.13 | Why? |
| Templates, Genetic | 2 | 2009 | 58 | 0.13 | Why? |
| Ubiquitination | 1 | 2014 | 343 | 0.13 | Why? |
| Proteome | 1 | 2003 | 1812 | 0.12 | Why? |
| Cations, Divalent | 1 | 2011 | 25 | 0.12 | Why? |
| Microscopy, Electron, Transmission | 2 | 2013 | 605 | 0.12 | Why? |
| Computational Biology | 3 | 2020 | 4514 | 0.12 | Why? |
| Puromycin | 1 | 2011 | 5 | 0.12 | Why? |
| Protons | 1 | 2011 | 64 | 0.12 | Why? |
| Muscles | 1 | 2012 | 152 | 0.11 | Why? |
| Adenosine Diphosphate Ribose | 2 | 2009 | 126 | 0.11 | Why? |
| Recombinant Proteins | 2 | 2020 | 3786 | 0.11 | Why? |
| Rodent Diseases | 1 | 2012 | 115 | 0.11 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.11 | Why? |
| Carcinoembryonic Antigen | 1 | 2012 | 140 | 0.11 | Why? |
| Sequence Homology, Nucleic Acid | 4 | 2003 | 368 | 0.11 | Why? |
| Cell Nucleus | 1 | 2014 | 399 | 0.11 | Why? |
| Inhibitory Concentration 50 | 1 | 2014 | 907 | 0.11 | Why? |
| Mammals | 1 | 2013 | 315 | 0.11 | Why? |
| Immunity, Innate | 3 | 2020 | 6570 | 0.11 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.11 | Why? |
| Binding Sites | 8 | 2020 | 6201 | 0.11 | Why? |
| Hepatocytes | 1 | 2014 | 549 | 0.11 | Why? |
| Zinc Compounds | 1 | 2010 | 62 | 0.11 | Why? |
| RNA, Small Interfering | 1 | 2015 | 817 | 0.10 | Why? |
| Viral Structural Proteins | 4 | 2007 | 491 | 0.10 | Why? |
| Mutagenesis | 3 | 2014 | 394 | 0.10 | Why? |
| Humans | 41 | 2021 | 930598 | 0.10 | Why? |
| Ribosomes | 2 | 1991 | 200 | 0.10 | Why? |
| Reassortant Viruses | 1 | 2012 | 287 | 0.10 | Why? |
| Sequence Analysis, DNA | 5 | 2012 | 2830 | 0.10 | Why? |
| Phylogeny | 5 | 2013 | 13341 | 0.10 | Why? |
| Vaccinia virus | 1 | 2012 | 346 | 0.10 | Why? |
| Immune Tolerance | 1 | 2014 | 608 | 0.10 | Why? |
| Virus Attachment | 1 | 2017 | 1259 | 0.10 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.10 | Why? |
| Cloning, Molecular | 6 | 2012 | 1036 | 0.10 | Why? |
| Dactinomycin | 1 | 2008 | 5 | 0.10 | Why? |
| Blotting, Western | 2 | 2010 | 863 | 0.10 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2010 | 249 | 0.09 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.09 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.09 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2014 | 482 | 0.09 | Why? |
| Enzyme Inhibitors | 1 | 2019 | 1881 | 0.09 | Why? |
| Macromolecular Substances | 1 | 2008 | 103 | 0.09 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.09 | Why? |
| Enzyme Activation | 1 | 2009 | 425 | 0.09 | Why? |
| DNA Probes | 2 | 2003 | 178 | 0.08 | Why? |
| 5' Untranslated Regions | 2 | 2020 | 375 | 0.08 | Why? |
| Sequence Analysis, RNA | 3 | 2018 | 2290 | 0.08 | Why? |
| Bacterial Proteins | 1 | 2016 | 1318 | 0.08 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.08 | Why? |
| Dose-Response Relationship, Drug | 1 | 2016 | 3776 | 0.08 | Why? |
| Immunoprecipitation | 1 | 2008 | 300 | 0.08 | Why? |
| Arteriviridae | 1 | 2006 | 10 | 0.08 | Why? |
| Cytoplasm | 1 | 2008 | 304 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Staining and Labeling | 1 | 2007 | 169 | 0.08 | Why? |
| RNA-Binding Proteins | 2 | 2004 | 1022 | 0.08 | Why? |
| Transmissible gastroenteritis virus | 1 | 2010 | 614 | 0.08 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2009 | 2134 | 0.07 | Why? |
| High-Throughput Screening Assays | 1 | 2014 | 1783 | 0.07 | Why? |
| Aging | 1 | 2021 | 3581 | 0.07 | Why? |
| Drug Approval | 1 | 2014 | 1325 | 0.07 | Why? |
| Reverse Genetics | 2 | 2021 | 439 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| HEK293 Cells | 4 | 2021 | 8394 | 0.07 | Why? |
| Viral Tropism | 1 | 2012 | 1329 | 0.07 | Why? |
| DNA, Single-Stranded | 1 | 2004 | 95 | 0.07 | Why? |
| Proteolysis | 2 | 2017 | 751 | 0.06 | Why? |
| Education, Medical | 1 | 2020 | 2461 | 0.06 | Why? |
| Immune Evasion | 1 | 2014 | 2081 | 0.06 | Why? |
| Protein Domains | 1 | 2016 | 6563 | 0.06 | Why? |
| Imaging, Three-Dimensional | 1 | 2008 | 680 | 0.06 | Why? |
| Peptide Fragments | 1 | 1993 | 2075 | 0.06 | Why? |
| HeLa Cells | 3 | 2017 | 1303 | 0.06 | Why? |
| Drug Design | 3 | 2020 | 2627 | 0.06 | Why? |
| Proteins | 1 | 2009 | 921 | 0.06 | Why? |
| Zinc | 2 | 2006 | 817 | 0.06 | Why? |
| Monosaccharide Transport Proteins | 1 | 2000 | 11 | 0.06 | Why? |
| Infectious bronchitis virus | 1 | 2009 | 856 | 0.05 | Why? |
| Immunohistochemistry | 1 | 2008 | 2275 | 0.05 | Why? |
| ATP-Binding Cassette Transporters | 1 | 2000 | 48 | 0.05 | Why? |
| Adenosylhomocysteinase | 1 | 2019 | 5 | 0.05 | Why? |
| Models, Molecular | 4 | 2020 | 7616 | 0.05 | Why? |
| Mutation, Missense | 1 | 2006 | 863 | 0.05 | Why? |
| Protein Conformation | 4 | 2014 | 4386 | 0.05 | Why? |
| Nucleic Acid Synthesis Inhibitors | 1 | 2019 | 43 | 0.05 | Why? |
| Genetic Vectors | 1 | 2007 | 1600 | 0.05 | Why? |
| Viral Matrix Proteins | 1 | 2008 | 1243 | 0.05 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2021 | 593 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Halogenation | 1 | 2019 | 51 | 0.05 | Why? |
| Escherichia coli Proteins | 1 | 2000 | 168 | 0.05 | Why? |
| Lopinavir | 1 | 2014 | 4308 | 0.05 | Why? |
| Protein Binding | 5 | 2020 | 11430 | 0.05 | Why? |
| Chloroquine | 1 | 2014 | 3152 | 0.05 | Why? |
| Gene Deletion | 1 | 2021 | 430 | 0.05 | Why? |
| Organelle Biogenesis | 1 | 2017 | 15 | 0.05 | Why? |
| Amino Acid Substitution | 1 | 2006 | 1706 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2016 | 10998 | 0.05 | Why? |
| Carps | 1 | 2018 | 30 | 0.05 | Why? |
| Cats | 3 | 2010 | 1890 | 0.04 | Why? |
| Frameshifting, Ribosomal | 2 | 2014 | 233 | 0.04 | Why? |
| Point Mutation | 1 | 2000 | 481 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2021 | 603 | 0.04 | Why? |
| Golgi Apparatus | 1 | 2017 | 178 | 0.04 | Why? |
| Models, Genetic | 1 | 1999 | 434 | 0.04 | Why? |
| Nidovirales Infections | 1 | 2016 | 17 | 0.04 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.04 | Why? |
| Prodrugs | 1 | 2019 | 264 | 0.04 | Why? |
| In Vitro Techniques | 2 | 2010 | 1027 | 0.04 | Why? |
| RNA Precursors | 1 | 1995 | 16 | 0.04 | Why? |
| Transfection | 1 | 1999 | 864 | 0.04 | Why? |
| Uridine Triphosphate | 1 | 2015 | 27 | 0.04 | Why? |
| Uridine | 1 | 2015 | 39 | 0.04 | Why? |
| Species Specificity | 2 | 2013 | 1356 | 0.04 | Why? |
| Guanosine Triphosphate | 1 | 2015 | 29 | 0.04 | Why? |
| Guanosine | 1 | 2015 | 29 | 0.04 | Why? |
| Sindbis Virus | 1 | 1995 | 32 | 0.04 | Why? |
| Catalysis | 2 | 2007 | 253 | 0.04 | Why? |
| Crystallization | 2 | 2009 | 331 | 0.04 | Why? |
| Body Temperature | 1 | 2021 | 875 | 0.04 | Why? |
| Receptors, Virus | 1 | 2012 | 5659 | 0.04 | Why? |
| Drug Evaluation, Preclinical | 2 | 2020 | 3347 | 0.04 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 13720 | 0.04 | Why? |
| Phosphates | 1 | 2015 | 135 | 0.04 | Why? |
| Mycophenolic Acid | 1 | 2017 | 383 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Gene Expression | 3 | 2016 | 3332 | 0.04 | Why? |
| Cysteine Endopeptidases | 2 | 2020 | 1557 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.03 | Why? |
| Cluster Analysis | 2 | 2013 | 3001 | 0.03 | Why? |
| Molecular Structure | 1 | 2019 | 1539 | 0.03 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Mutant Proteins | 1 | 2014 | 328 | 0.03 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.03 | Why? |
| Adenosine Triphosphatases | 2 | 2005 | 78 | 0.03 | Why? |
| Recombinant Fusion Proteins | 2 | 2000 | 919 | 0.03 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.03 | Why? |
| Nucleosides | 1 | 2015 | 221 | 0.03 | Why? |
| Genomics | 2 | 2021 | 3118 | 0.03 | Why? |
| Mesocricetus | 1 | 2018 | 1847 | 0.03 | Why? |
| Gene Order | 1 | 2012 | 144 | 0.03 | Why? |
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 56 | 0.03 | Why? |
| Sequence Homology | 1 | 1993 | 448 | 0.03 | Why? |
| Restriction Mapping | 1 | 1990 | 55 | 0.03 | Why? |
| Escherichia coli | 2 | 2010 | 1547 | 0.03 | Why? |
| Protein Isoforms | 1 | 2012 | 347 | 0.03 | Why? |
| Nucleocapsid Proteins | 2 | 2000 | 3120 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Models, Biological | 1 | 2008 | 4907 | 0.03 | Why? |
| tRNA Methyltransferases | 1 | 2010 | 19 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Leupeptins | 1 | 2010 | 49 | 0.03 | Why? |
| Boronic Acids | 1 | 2010 | 30 | 0.03 | Why? |
| Glycerophosphates | 1 | 2009 | 6 | 0.03 | Why? |
| Ionophores | 1 | 2010 | 60 | 0.03 | Why? |
| Protein Transport | 1 | 2012 | 487 | 0.03 | Why? |
| Brefeldin A | 1 | 2009 | 20 | 0.03 | Why? |
| Selenomethionine | 1 | 2009 | 9 | 0.03 | Why? |
| DNA, Complementary | 1 | 2012 | 568 | 0.02 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.02 | Why? |
| Bortezomib | 1 | 2010 | 125 | 0.02 | Why? |
| Proteasome Inhibitors | 1 | 2010 | 127 | 0.02 | Why? |
| Global Health | 1 | 2013 | 13911 | 0.02 | Why? |
| Protease Inhibitors | 2 | 2020 | 3630 | 0.02 | Why? |
| Coronavirus NL63, Human | 1 | 2015 | 669 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.02 | Why? |
| Static Electricity | 1 | 2010 | 397 | 0.02 | Why? |
| Blotting, Northern | 1 | 2007 | 51 | 0.02 | Why? |
| Two-Hybrid System Techniques | 1 | 2008 | 116 | 0.02 | Why? |
| DNA, Viral | 3 | 2000 | 2521 | 0.02 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.02 | Why? |
| Microscopy, Confocal | 1 | 2009 | 343 | 0.02 | Why? |
| Cattle Diseases | 1 | 1991 | 294 | 0.02 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 382 | 0.02 | Why? |
| Organ Specificity | 1 | 2012 | 1070 | 0.02 | Why? |
| Mice, Knockout | 1 | 2012 | 1815 | 0.02 | Why? |
| Protein Interaction Maps | 1 | 2014 | 1333 | 0.02 | Why? |
| Horse Diseases | 1 | 2007 | 101 | 0.02 | Why? |
| Dimerization | 1 | 2008 | 475 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| NF-kappa B | 1 | 2014 | 1301 | 0.02 | Why? |
| Oligopeptides | 1 | 2010 | 576 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Ultraviolet Rays | 1 | 1995 | 1272 | 0.02 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.02 | Why? |
| Virus Internalization | 2 | 2017 | 7921 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Coronavirus, Bovine | 1 | 2007 | 289 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2013 | 2886 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Netherlands | 1 | 2012 | 3533 | 0.02 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.02 | Why? |
| Sequence Analysis, Protein | 1 | 2004 | 309 | 0.02 | Why? |
| 3' Untranslated Regions | 1 | 2004 | 318 | 0.02 | Why? |
| Dendritic Cells | 1 | 2012 | 1330 | 0.02 | Why? |
| Sequence Deletion | 1 | 2007 | 674 | 0.02 | Why? |
| Protein Structure, Secondary | 1 | 2007 | 1077 | 0.02 | Why? |
| Databases, Protein | 1 | 2007 | 523 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.01 | Why? |
| Virulence | 1 | 2009 | 2172 | 0.01 | Why? |
| Maltose-Binding Proteins | 1 | 2000 | 8 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2012 | 5542 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| GTP Phosphohydrolases | 1 | 2000 | 89 | 0.01 | Why? |
| Subcellular Fractions | 1 | 1999 | 25 | 0.01 | Why? |
| Lysosome-Associated Membrane Glycoproteins | 1 | 1999 | 30 | 0.01 | Why? |
| Structure-Activity Relationship | 1 | 2006 | 2219 | 0.01 | Why? |
| Coronavirus OC43, Human | 1 | 2007 | 1157 | 0.01 | Why? |
| Pyrazines | 1 | 2010 | 1783 | 0.01 | Why? |
| Sodium Chloride | 1 | 2000 | 203 | 0.01 | Why? |
| Viral Envelope Proteins | 1 | 1991 | 3539 | 0.01 | Why? |
| Chiroptera | 1 | 2014 | 3530 | 0.01 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 393 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2014 | 11304 | 0.01 | Why? |
| Carrier Proteins | 1 | 2000 | 513 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Endocytosis | 1 | 1999 | 451 | 0.01 | Why? |
| Endosomes | 1 | 1999 | 490 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| DNA | 2 | 1991 | 778 | 0.01 | Why? |
| Brain | 1 | 2012 | 5133 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Antigens, CD | 1 | 1999 | 984 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Female | 3 | 2021 | 380317 | 0.01 | Why? |
| Virus Diseases | 1 | 1991 | 3779 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Togaviridae | 1 | 1991 | 12 | 0.01 | Why? |
| Cell Compartmentation | 1 | 1991 | 24 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Molecular Weight | 1 | 1991 | 249 | 0.01 | Why? |
| Nucleic Acid Hybridization | 1 | 1991 | 140 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Calorimetry | 1 | 1990 | 66 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Biological Transport | 1 | 1991 | 290 | 0.01 | Why? |
| Membrane Glycoproteins | 1 | 1999 | 2273 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Base Composition | 1 | 1990 | 203 | 0.01 | Why? |
| Evaluation Studies as Topic | 1 | 1991 | 391 | 0.01 | Why? |
| Thermodynamics | 1 | 1991 | 873 | 0.01 | Why? |
| Cattle | 1 | 1991 | 1336 | 0.00 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |
| Membrane Proteins | 1 | 1991 | 1733 | 0.00 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 7868 | 0.00 | Why? |
| Serine Endopeptidases | 1 | 1991 | 4606 | 0.00 | Why? |
| Antigens, Viral | 1 | 1991 | 6298 | 0.00 | Why? |
| Sensitivity and Specificity | 1 | 1991 | 22971 | 0.00 | Why? |